News
13h
Stockhead on MSNImagion shares rally after positive FDA feedback on path to phase II breast cancer trialImagion Biosystems receives positive feedback from US FDA for HER2 breast cancer phase II clinical trial. ... Read More The ...
1don MSN
Gilead Sciences, Inc. (NASDAQ:GILD) is one of the 10 Best Cheap Stocks to Buy According to Billionaire Ray Dalio. Bridgewater Associates holds over $56 million worth of shares of GILD, which ...
Viking Therapeutics jumped by 9.74 percent on Tuesday to close at $30.19 apiece as investors repositioned portfolios ahead of ...
BEACON and Open-Label Extension Study Design and Data Summary: ...
In the Phase 1 portion of the CELC-G-201 clinical trial evaluating gedatolisib plusdarolutamide in men with metastatic castration resistant prostate cancer ("mCRPC"),the six-month radiographic progres ...
AL amyloidosis is caused by abnormal plasma cells in the bone marrow, which produce misfolded amyloid proteins that circulate in the blood, then build-up in the heart, kidney, liver, and other organs.
The Phase III BASIS trial found that once-weekly subcutaneous Hympavzi reduced treated bleed rates by 93% in patients with ...
2don MSN
Researchers have provided robust scientific evidence that ailments like depression, high blood pressure, diabetes mellitus, ...
The clinical trial support services market is experiencing significant growth, driven by the increasing incidence of chronic illnesses such as cancer, diabetes, and cardiovascular diseases. This rise ...
Summit Therapeutics nears a $15B AstraZeneca deal for ivonescimab, targeting a $90B market. See more on the potential and ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results